+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast

  • ID: 4083183
  • Report
  • February 2017
  • Region: Estonia, Latvia, Lithuania
  • 71 Pages
  • Renub Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
In Terms of Children Vaccination, Lithuania & Latvia Hold Nearly 70 Percent Market Share in 2016 Whereas, in Adult Vaccination Segments, These Two Will Share More Than 95 Percent Market Share by 2022

According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania & Latvia hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 95 percent market share by 2022.

This report provides a complete analysis of 3 Baltic Countries (Lithuania, Estonia, Latvia) Seasonal Influenza Vaccine Market (Child & Adult), Number of Vaccinated Population (Child & Adult) and Forecast till 2022. All 3 countries in the report have been studied from 2 viewpoints.

1. Seasonal Influenza Vaccine Market in Baltic Countries (2011 - 2022)

  • Seasonal Influenza Vaccine Market & Forecast
  • Children Seasonal Influenza Vaccine Market & Forecast
  • Adult Seasonal Influenza Vaccine Market & Forecast

2. Seasonal Influenza Vaccinated Population in Baltic Countries (2011 - 2022)

  • Seasonal Influenza Vaccinated Population & Forecast
  • Children Seasonal Influenza Vaccinated Population & Forecast
  • Adult Seasonal Influenza Vaccinated Population & Forecast

Countries Studied in the Report are as Follows:

  • Lithuania
  • Estonia
  • Latvia

Note: This report offers 10% free customization.
Note: Product cover images may vary from those shown
2 of 3

1. Executive Summary

2. Baltic Countries Seasonal Influenza Vaccinated Population
    2.1 Seasonal Influenza Vaccinated Child Population in Baltic Countries
    2.2 Baltic Countries Seasonal Influenza Vaccinated Adult Population

3. Baltic Countries Seasonal Influenza Vaccine Market
    3.1 Seasonal Influenza Child Vaccine Market in Baltic Countries
    3.2 Seasonal Influenza Adult Vaccine Market in Baltic Countries

4. Baltic Countries Seasonal Influenza Vaccine Market Share Analysis
    4.1 Seasonal Influenza Vaccine Market Share
    4.2 Seasonal Influenza Child Vaccine Market Share
    4.3 Baltic Countries - Seasonal Influenza Adult Vaccine Market Share

5. Estonia
    5.1 Estonia Seasonal Influenza Vaccinated Population Analysis
        5.1.1 Estonia Seasonal Influenza Vaccinated Population
        5.1.2 Estonia Seasonal Influenza Vaccinated Child Population
        5.1.3 Estonia Seasonal Influenza Vaccinated Adult Population
    5.2 Estonia Seasonal Influenza Vaccine Market Analysis
        5.2.1 Estonia Seasonal Influenza Vaccine Market
        5.2.2 Estonia Seasonal Influenza Child Vaccine Market
        5.2.3 Estonia Seasonal Influenza Adult Vaccine Market

6. Latvia
    6.1 Latvia Seasonal Influenza Vaccinated Population Analysis
        6.1.1 Latvia Seasonal Influenza Vaccinated Population
        6.1.2 Latvia Seasonal Influenza Vaccinated Child Population
        6.1.3 Latvia Seasonal Influenza Vaccinated Adult Population
    6.2 Latvia Seasonal Influenza Vaccine Market Analysis
        6.2.1 Latvia Seasonal Influenza Vaccine Market
        6.2.2 Latvia Seasonal Influenza Child Vaccine Market
        6.2.3 Latvia Seasonal Influenza Adult Vaccine Market

7. Lithuania
    7.1 Lithuania Seasonal Influenza Vaccinated Population Analysis
        7.1.1 Lithuania Seasonal Influenza Vaccinated Population
        7.1.2 Lithuania Seasonal Influenza Vaccinated Child Population
        7.1.3 Lithuania Seasonal Influenza Vaccinated Adult Population
    7.2 Lithuania Seasonal Influenza Vaccine Market Analysis
        7.2.1 Lithuania Seasonal Influenza Vaccine Market
        7.2.2 Lithuania Seasonal Influenza Child Vaccine Market
        7.2.3 Lithuania Seasonal Influenza Adult Vaccine Market

8. Seasonal Influenza Vaccine - Growth Drivers
    8.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
    8.2 Growing Children & Ageing Population in Baltic Region
    8.3 Rising Healthcare Expenditure Share of the Baltic Countries GDP

9. Seasonal Influenza Vaccine - Challenges
    9.1 Regulatory Challenges with New and Novel Influenza Vaccines
    9.2 Lack of Healthcare Infrastructure
    9.3 Limited Reimbursement and Access to the Vaccines

List of Figures
Figure 2 1: Baltic Countries - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 2 2: Baltic Countries - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 2 3: Baltic Countries - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: Baltic Countries - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: Baltic Countries - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: Baltic Countries - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: Baltic Countries - Seasonal Influenza Vaccine Market (Thousand), 2011 - 2016
Figure 3 2: Baltic Countries - Forecast for Seasonal Influenza Vaccine Market (Thousand), 2017 - 2022
Figure 3 3: Baltic Countries - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 4: Baltic Countries - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 3 5: Baltic Countries - Seasonal Influenza Adult Vaccine Market (Thousand), 2011 - 2016
Figure 3 6: Baltic Countries - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand), 2017 - 2022
Figure 4 1: Baltic Countries - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Figure 4 2: Baltic Countries - Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Figure 4 3: Baltic Countries - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Figure 4 4: Baltic Countries - Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Figure 4 5: Baltic Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Figure 4 6: Baltic Countries - Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Figure 5 1: Estonia - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 5 2: Estonia -Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 5 3: Estonia- Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Estonia- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Estonia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Estonia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Estonia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 8: Estonia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 9: Estonia - Seasonal Influenza Children Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 10: Estonia - Forecast for Seasonal Influenza Children Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 11: Estonia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 12: Estonia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 1: Latvia - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 6 2: Latvia - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 6 3: Latvia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Latvia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Latvia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Latvia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Latvia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 8: Latvia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 9: Latvia- Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 10: Latvia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 1: Lithuania - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 7 2: Lithuania - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 7 3: Lithuania - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: Lithuania - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: Lithuania - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: Lithuania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 7 7: Lithuania - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 8: Lithuania - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 9: Lithuania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 10: Lithuania - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 11: Lithuania - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 12: Lithuania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 1: Vaccine Manufacturers - Influenza Vaccine Production (Million Doses), 2013-2015
Figure 8 2: Baltic Countries - Children Population (Thousand), 2010 - 2016
Figure 8 3: Baltic Countries - Forecast for Children Population (Thousand), 2017 - 2022
Figure 8 4: Baltic Countries - Ageing Population (Thousand), 2010 - 2016
Figure 8 5: Baltic Countries - Forecast for Ageing Population (Thousand), 2017 - 2022
Figure 9 1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019

List of Tables
Table 8 1: Baltic Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 - 2015

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll